111
|
|
|
V-set and transmembrane domain containing 4 |
C10orf72 |
|
112
|
|
|
V-set and transmembrane domain containing 5 |
C11orf90 |
|
113
|
|
|
Visual system homeobox 1 |
CAASDS, KTCN, KTCN1, PPCD, PPCD1, PPD, RINX |
Auditory perceptual disorder, Color vision deficiency, Corneal dystrophy, Craniofacial abnormalities, Craniofacial anomalies with anterior segment dysgenesis, Eye abnormalities, Long qt syndrome, Hereditary corneal dystrophy, Keratoconus, Polymorphous corneal dystrophy, Posterior polymorphous corneal dystrophy |
114
|
|
|
Visual system homeobox 2 |
CHX10, HOX10, MCOP2, MCOPCB3, RET1 |
Anophthalmia/microphthalmia-esophageal atresia syndrome, Anophthalmia, Blindness, Breast cancer, Colobomatous microphthalmia, Congenital cystic eyeball, Crohn disease, Inflammatory bowel disease, Microphthalmia, Microphthalmos, Ocular sarcoidosis, Retinitis pigmentosa, Ulcerative colitis |
115
|
|
|
Vesicle trafficking 1 |
6orf55, C6orf55, DRG-1, DRG1, HSPC228, LIP5, My012, SBP1 |
|
116
|
|
|
V-set domain containing T cell activation inhibitor 1 |
B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291, VCTN1 |
|
117
|
|
|
Vesicle transport through interaction with t-SNAREs 1A |
MMDS3, MVti1, VTI1RP2, Vti1-rp2 |
Alzheimer disease, Atherosclerosis, Attention deficit hyperactivity disorder, Central nervous system cancer, Colorectal adenoma, Colorectal cancer, Colorectal neoplasms, Dementia, Diabetes mellitus, Glioma, Heart failure, Hypertrophic cardiomyopathy, Immune system disease, Lung cancer, Migraine, Multiple sclerosis, Non-small cell lung carcinoma, Osteoporosis, Squamous cell carcinoma, Substance abuse, Diabetes mellitus type 2View all (6 more) |
118
|
|
|
Vitronectin |
V75, VN, VNT |
|
119
|
|
|
Von Willebrand factor A domain containing 1 |
HMNMYO, HMNR7, WARP |
|
120
|
|
|
Von Willebrand factor A domain containing 2 |
AMACO, CCSP-2, CCSP2, NET42 |
|